New England Private Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

New England Private Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $198,070 - $258,364	-4,025 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $172,149 - $204,107	4,025 New	4,025 $203,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $201,866 - $261,772	-4,140 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $5,684 - $6,411	-103 Reduced 2.43%	4,140 $257,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $42,192 - $52,588	-835 Reduced 16.44%	4,243 $236,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $12,403 - $14,278	207 Added 4.25%	5,078 $322,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $12,107 - $13,200	-202 Reduced 3.98%	4,871 $300,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $280,181 - $323,353	5,073	5,073 $324,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.